Clinical trials
Small Cell Lung Carcinoma trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Recruiting | 7 |
| Completed | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Peng Zhang | 2 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 1 |
| China-Japan Friendship Hospital | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
| General Hospital of Ningxia Medical University | 1 |
| Haibo Zhang | 1 |
| Henan Cancer Hospital | 1 |
| LI FENG | 1 |
| Peking University First Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 22 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Lung Neoplasms | 3 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
| Cholangiocarcinoma | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.